Close
Almac
Achema middle east

News

Exeter University and Medicines Discovery Catapult collaborate on R&D drive

The collaboration will focus on identifying promising innovations that can be adopted through the industry in the ultimate hope of benefitting patients. The collaboration will combine the world-class research at the University of Exeter with MDC’s industry skills, discovery...

UK government secures 5 million doses of Moderna’s Covid-19 vaccine

The agreement follows negotiations with Moderna, who recently reported that interim data for its vaccine-candidate shows it is nearly 95% effective. The 5 millions doses would be enough for up to 2.5 million people in the UK, given that...

Moderna and Pfizer COVID Vaccines: The Comparison

Moderna Inc. on Monday declared that its vaccine was 94.5% effective. This came just after a week when Pfizer & its partner BioNTech SE had gone public to state that their vaccine is more than 90% effective. There is...

Virgin Atlantic Cargo launches new pharma service as it prepares for vaccine

Virgin Atlantic Cargo has added a new pharma service ahead of the launch of a new Covid-19 vaccine. The airline said its new Pharma Secure service will cater for urgent, valuable and vulnerable pharmaceutical and life sciences shipments. The product...

Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the government of the United Kingdom to supply mRNA-1273, its COVID-19 vaccine...

EUA Begins Rolling Review of Modernas mRNA Vaccine Candidate Against COVID-19

Moderna, Inc.,a biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the EMA human medicines committee (CHMP) has started a rolling review of mRNA-1273, the Company’s vaccine candidate...

COVID-19 Genomics UK Consortium gets £12.2 million funding to expand whole genome sequencing of SARS-CoV-2 virus

The public will be better protected from COVID-19 with £12.2 million of funding awarded to potentially life-saving research into how the virus spreads and evolves through genome sequencing. The COVID-19 Genomics UK (COG-UK) Consortium will use the funding to expand...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »